Clinical Trial Update: The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile [Phase 4]

View source ↗

Summary

Phase 4 trial investigating early administration of a PCSK9 inhibitor in acute ischemic stroke patients with atherosclerosis to assess effects on stroke prognos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute Ischemic

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Sun U. Kwon | Conditions: Stroke, Acute Ischemic, PCSK9 Inhibitor | Phase 4 | Status: NOT_YET_RECRUITING